SCHEMBL4320658

SCHEMBL4320658

CCOC(=O)C(CCC(C)c1ccc(Br)cc1)c1ncco1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
TDP1 Q9NUW8 1/20 0.40
FPR2 P25090 5/20 0.38
TP53 P04637 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CTSA P10619 4/20 0.34
TARBP2 Q15633 1/20 0.33
HTT P42858 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.33
S1PR4 O95977 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
S1PR1 P21453 1/20 0.33
MAPK1 P28482 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSD11B1 P28845 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4335154 0.88 TDP1 (0.40) MEN1KMT2ATDP1SMN1; SMN2CTSA
SCHEMBL4329564 0.86 CTSA (0.36) KMT2ASMN1; SMN2CTSAHTTALDH1A1
SCHEMBL4338765 0.84 FFAR2 (0.36) SMN1; SMN2CTSAALDH1A1
SCHEMBL4325302 0.77 FPR2 (0.38) MEN1KMT2ATDP1FPR2CTSA
SCHEMBL4327553 0.74 CTSA (0.41) CTSA
SCHEMBL4336867 0.73 TSHR (0.38) CTSATSHR
SCHEMBL4335078 0.73 CTSA (0.38) MEN1KMT2ATDP1TP53SMN1; SMN2
SCHEMBL27406420 0.72 GPR119 (0.38) MEN1KMT2ATDP1SMN1; SMN2CTSA
SCHEMBL4322072 0.71 CTSA (0.40) MEN1KMT2ATDP1SMN1; SMN2CTSA
SCHEMBL4341790 0.71 CTSA (0.40) MEN1KMT2ATDP1SMN1; SMN2CTSA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7521563-B2 Hydroxamic acid derivative and medicine containing the same as active ingredient SHIZUOKA COFFEIN CO., LTD. (JP) 2009-04-21 US disclosed
US-20070208065-A1 Hydroxamic Acid Derivative and Medicine Containing the Same as Active Ingredient SHIZUOKA COFFEIN CO., LTD. (JP) 2007-09-06 US disclosed
EP-1787986-A1 HYDROXAMIC ACID DERIVATIVE AND MEDICINE CONTAINING THE SAME AS ACTIVE INGREDIENT SHIZUOKA COFFEIN CO., LTD. (JP) 2007-05-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070208065-A1 Hydroxamic Acid Derivative and Medicine Containing the Same as Active Ingredient IL6, IL1A, TNF MEN1 3484/4885KMT2A 1615/4885TDP1 3500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.